Women’s Health Considerations in Eosinophilic Esophagitis
The Journal of Allergy and Clinical Immunology: In Practice · 2026-11 · 14 (11) · 2511-2515
DOI: 10.1016/j.jaip.2026.08.017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-11. Verfasst von Jenny Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, University of California, San Diego, San Diego, Calif. Electronic address: jeh079@health.ucsd.edu. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Women's Health, Pregnancy Complications. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Although eosinophilic esophagitis is traditionally recognized as a male-predominant disease, its distinct presentation, underlying biology, and management in female patients warrant closer examination. Differing gene profiles between sexes and sex-specific genetic loci associated with disease development have been identified. Estrogen has been shown to have a protective role in eosinophilic esophagitis development; this may factor into the observed male predominance. Women tend to have less dysphagia and are more likely to experience the inflammatory symptoms of abdominal pain, nausea, reflux, heartburn, chest pain, and epigastric pain. Females are also less likely than males to have strictures. Data on endoscopic and histologic findings between females and males are variable, with data suggesting that females tend to have less severe disease activity but similar or higher levels of symptoms and quality-of-life impairment. When it comes to pregnancy, symptoms can improve during pregnancy but may recur after delivery. Data suggest that proton pump inhibitors, swallowed budesonide, and dupilumab may be safely continued during pregnancy. Elimination diets should be approached cautiously due to the potential for adverse outcomes associated with food restriction but could be considered under the supervision of a knowledgeable dietician. Further research is needed to better understand and treat eosinophilic esophagitis in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, University of California, San Diego, San Diego, Calif. Electronic address: jeh079@health.ucsd.edu.
- Section of Allergy and Clinical Immunology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine, Lebanon, NH.
- Section of Pediatric Allergy & Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
- Division of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Va.
Zitieren
APA
Huang, J., Hsu Blatman, K. S., Bauer, M., & McGowan, E. C. (2026). Women’s Health Considerations in Eosinophilic Esophagitis. The Journal of Allergy and Clinical Immunology: In Practice, 14(11), 2511-2515. https://doi.org/10.1016/j.jaip.2026.08.017
Vancouver
Huang J, Hsu Blatman KS, Bauer M, McGowan EC. Women’s Health Considerations in Eosinophilic Esophagitis. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(11):2511-2515. doi:10.1016/j.jaip.2026.08.017
BibTeX
@article{Huang2026,
author = {Huang, Jenny and Hsu Blatman, Karen S and Bauer, Maureen and McGowan, Emily C},
title = {Women’s Health Considerations in Eosinophilic Esophagitis},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
volume = {14},
number = {11},
pages = {2511--2515},
doi = {10.1016/j.jaip.2026.08.017}
}
EUVIMED